Program: ASH Poster Walks
Hematology Disease Topics & Pathways:
Research, clinical trials, Sickle Cell Disease, adult, epidemiology, elderly, Clinical Research, health outcomes research, health disparities research, Diversity, Equity, and Inclusion (DEI) , Hemoglobinopathies, pediatric, patient-reported outcomes, Diseases, real-world evidence, pregnant, registries, young adult , Study Population, Human
Hematology Disease Topics & Pathways:
Research, clinical trials, Sickle Cell Disease, adult, epidemiology, elderly, Clinical Research, health outcomes research, health disparities research, Diversity, Equity, and Inclusion (DEI) , Hemoglobinopathies, pediatric, patient-reported outcomes, Diseases, real-world evidence, pregnant, registries, young adult , Study Population, Human
Wednesday, December 14, 2022: 10:00 AM-11:00 AM
(VIRTUAL PROGRAM)
Sickle cell disease (SCD) affects 100,000 people living in the US and 250-300,000 births annually worldwide. Despite its frequency, the natural history of SCD and its complications remain poorly understood. Over the past decade, clinical research has led to much progress in disease management, identifying novel therapeutic targets and FDA approval of two new therapies, crizanlizumab and voxelotor, in the fall of 2019. Numerous clinical trials of novel therapeutics and potential curative therapies are ongoing. Large patient registries from the US and Europe have begun to increase our understanding of the disease and its complications.
This poster walk will highlight six abstracts focused on innovative clinical research and promising ongoing trials in SCD.
See more of: ASH Poster Walks